Literature DB >> 31898472

Do Free Trade Agreements Matter to Drug Lag? Recent Evidence From Korea After the Korea-U.S. Free Trade Agreement.

Kyung-Bok Son1.   

Abstract

Entities:  

Keywords:  KORUS FTA; South Korea; access to medicines; drug lag; free trade agreement

Mesh：

Substances：

Year:  2020        PMID： 31898472     DOI： 10.1177/0020731419898335

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN： 0020-7314            Impact factor:   1.663


× No keyword cloud information.
  4 in total

Review 1.  What is the impact of intellectual property rules on access to medicines? A systematic review.

Authors:  Brigitte Tenni; Hazel V J Moir; Belinda Townsend; Burcu Kilic; Anne-Maree Farrell; Tessa Keegel; Deborah Gleeson
Journal:  Global Health       Date:  2022-04-15       Impact factor: 10.401

2.  Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs.

Authors:  Jennifer E Miller; Michelle M Mello; Joshua D Wallach; Emily M Gudbranson; Blake Bohlig; Joseph S Ross; Cary P Gross; Peter B Bach
Journal:  JAMA Netw Open       Date:  2021-05-03

3.  Perceived impact of the patent linkage system on pharmaceutical market from the viewpoint of the domestic manufacturers in South Korea.

Authors:  Nahye Choi; Kyung-Bok Son; Joonsoo Byun; Dong-Wook Yang
Journal:  Global Health       Date:  2022-03-21       Impact factor: 4.185

4.  Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea.

Authors:  Kyung-Bok Son; Sylvia Park
Journal:  Front Med (Lausanne)       Date:  2022-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.